SSI Diagnostica A/S: Financial statements 2017
CVR: 37294535
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
SSI Diagnostica A/S (CVR 37294535) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 93,315,073 and a net result of DKK 18,547,652 compared with DKK 11,950,630 the year before. That is an increase of 180.8% compared with the year before. Equity in the 2017 report amounted to DKK 63,837,282. The solvency ratio was 21.7%.
- Gross Profit
- DKK 93,315,073
- Profit/Loss
- DKK 18,547,652
- Equity
- DKK 63,837,282
- Total Assets
- DKK 294,017,568
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 93.3M | 18.5M | 63.8M | - |
| 2016 | - | 33.2M | 12M | 45.3M | - |
Official annual report
Keep an eye on SSI Diagnostica A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
SSI Diagnostica A/S has published its annual report for 2016. Gross profit came to DKK 33,236,801, and the net result was DKK 11,950,630.
About SSI Diagnostica A/S
SSI Diagnostica A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Christina Charlotte Lindved and Lars Henrik Vejrup Hansen. The board consists of Nachum Shamir (chair), Ingo Sujit Michael Chakravarty, Joseph Edward Bernardo and Patrik Olof Dahlén. The company is owned by SSI Diagnostica Holding A/S. The company has 151 employees (2026). In 2025, the company reported revenue of DKK 320,248,428 and a net result of DKK -107,420,232 compared with DKK -57,738,206 the year before. Equity in the 2025 report amounted to DKK 695,791,068.